Avidity Biosciences, Inc. / Atrium Therapeutics, Inc. Spin-Off (RNA)
Avidity Biosciences, Inc. appears to be separating Atrium Therapeutics, Inc.. No strategic rationale disclosed in this 8-K; separation rationale resides in the Form 10-12B filing. Form 10 status: FILED.